Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Capital Expenditures (2016 - 2022)

Historic Capital Expenditures for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Q3 2022 value amounting to $716000.0.

  • Avadel Pharmaceuticals' Capital Expenditures changed N/A to $716000.0 in Q3 2022 from the same period last year, while for Dec 2022 it was $716000.0, marking a year-over-year increase of 265384.62%. This contributed to the annual value of $716000.0 for FY2022, which is 265384.62% up from last year.
  • According to the latest figures from Q3 2022, Avadel Pharmaceuticals' Capital Expenditures is $716000.0.
  • Over the past 5 years, Avadel Pharmaceuticals' Capital Expenditures peaked at $716000.0 during Q3 2022, and registered a low of -$1000.0 during Q2 2019.
  • For the 5-year period, Avadel Pharmaceuticals' Capital Expenditures averaged around $104700.0, with its median value being $37000.0 (2018).
  • Its Capital Expenditures has fluctuated over the past 5 years, first surged by 54615.38% in 2018, then tumbled by 10172.41% in 2019.
  • Over the past 5 years, Avadel Pharmaceuticals' Capital Expenditures (Quarter) stood at $11000.0 in 2018, then plummeted by 109.09% to -$1000.0 in 2019, then surged by 6600.0% to $65000.0 in 2020, then crashed by 60.0% to $26000.0 in 2021, then skyrocketed by 2653.85% to $716000.0 in 2022.
  • Its Capital Expenditures was $716000.0 in Q3 2022, compared to $26000.0 in Q1 2021 and $65000.0 in Q4 2020.